Tussenevaluatie POP3-maatregelen cluster Concurrentiekracht

Het Plattelandsontwikkelingsprogramma Nederland 2014-2020 (POP3) beoogt de innovatie en een duurzame modernisering van de agrarische sector te bevorderen. Versterking van biodiversiteit en vitaal platteland zijn andere belangrijke doelen. Het programma wordt zowel tijdens de looptijd als na afloop geëvalueerd. In 2019 dient Nederland aan de Europese Commissie te rapporteren over de voortgang van het POP3 over de periode 2014-2018. In dit rapport wordt inzicht gegeven in de voortgang in deze periode van vier maatregelen uit het cluster Concurrentiekracht: Kwaliteitsregeling Kalveren, Productieve fysieke investeringen, Jonge Landbouwersregeling en Verbetering verkaveling. Deze maatregelen beogen het POP3-doel versterken van de agrarische bedrijfsstructuur. In deze tussenevaluatie wordt inzicht gegeven in het bereik (in welke mate worden begrote budgetten en streefwaarden bereikt) en de mate van doeltreffendheid, waarin zowel ingegaan wordt op gerealiseerde als nog te verwachten effecten in komende jaren van de ingezette middelen. Ook wordt inzicht gegeven in de uitvoering en organisatie van de vier maatregelen, waarbij ook aanbevelingen worden gedaan voor aanpassing van de uitvoering

Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial)

Contains fulltext : 69534.pdf (publisher's version ) (Open Access)BACKGROUND: With the availability of infliximab, nowadays recurrent Crohn's disease, defined as disease refractory to immunomodulatory agents that has been treated with steroids, is generally treated with infliximab. Infliximab is an effective but expensive treatment and once started it is unclear when therapy can be discontinued. Surgical resection has been the golden standard in recurrent Crohn's disease. Laparoscopic ileocolic resection proved to be safe and is characterized by a quick symptom reduction.The objective of this study is to compare infliximab treatment with laparoscopic ileocolic resection in patients with recurrent Crohn's disease of the distal ileum with respect to quality of life and costs. METHODS/DESIGN: The study is designed as a multicenter randomized clinical trial including patients with Crohn's disease located in the terminal ileum that require infliximab treatment following recent consensus statements on inflammatory bowel disease treatment: moderate to severe disease activity in patients that fail to respond to steroid therapy or immunomodulatory therapy. Patients will be randomized to receive either infliximab or undergo a laparoscopic ileocolic resection. Primary outcomes are quality of life and costs. Secondary outcomes are hospital stay, early and late morbidity, sick leave and surgical recurrence. In order to detect an effect size of 0.5 on the Inflammatory Bowel Disease Questionnaire at a 5% two sided significance level with a power of 80%, a sample size of 65 patients per treatment group can be calculated. An economic evaluation will be performed by assessing the marginal direct medical, non-medical and time costs and the costs per Quality Adjusted Life Year (QALY) will be calculated. For both treatment strategies a cost-utility ratio will be calculated. Patients will be included from December 2007. DISCUSSION: The LIR!C-trial is a randomized multicenter trial that will provide evidence whether infliximab treatment or surgery is the best treatment for recurrent distal ileitis in Crohn's disease. TRIAL REGISTRATION: Nederlands Trial Register NTR1150

Impact assessment of EC 2030 Green Deal Targets for sustainable crop production

In this report we present an Impact Assessment on six objectives of the Farm to Fork and Biodiversity strategies with respect to reduction of pesticide use and risk, reduction of nutrient losses, increase of the area in the EU under organic production and increase of the amount of agricultural land under high-diversity landscape features. Four scenarios have been developed for which the impacts have been assessed: (1) reduction of use and risk of pesticides, (2) reduction of use and losses of nutrients, (3) increase of area under organic production and (4) a combination of the Scenarios 1 and 2 extended with the added objective to have more land with high-diversity landscape features. The impact assessment has been executed at farm level, covering ten crops and seven case countries across the EU. The results of the case studies have been used to explore the consequences of these objectives for the production volume of the crops in the EU, market prices, the international trade and indirect land use

Kijk op multifunctionele landbouw : Omzet 2007-2018

De omzet in de multifunctionele landbouw in Nederland is tussen 2013 en 2018 bijna verdubbeld tot 887 miljoen euro. Dit blijkt uit recent onderzoek van Wageningen University & Research in de reeks ‘Kijk op multifunctionele landbouw’ in opdracht van het ministerie van Landbouw, Natuur en Voedselkwaliteit

Kijk op multifunctionele landbouw : Omzet 2007-2020

De omzet in de multifunctionele landbouw in Nederland is ondanks de coronapandemie tussen 2018 en 2020 gestegen met 15% tot ruim een miljard euro. Dit blijkt uit recent onderzoek van Wageningen University & Research in de reeks ‘Kijk op multifunctionele landbouw’ in opdracht van het ministerie van Landbouw, Natuur en Voedselkwaliteit. De belangrijkste resultaten hiervan zijn per activiteit samengevat in deze brochure